Eaton Vance Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-958
| Closed | -$26K | – | 2382 |
|
|
2021
Q4 | $26K | Sell |
958
-724
| -43% | -$19.6K | ﹤0.01% | 2328 |
|
|
2021
Q3 | $0 | Sell |
1,682
-233
| -12% | – | ﹤0.01% | 2446 |
|
|
2021
Q2 | $59K | Buy |
1,915
+1,334
| +230% | +$41.1K | ﹤0.01% | 2102 |
|
|
2021
Q1 | $18K | Buy |
+581
| New | +$18K | ﹤0.01% | 2130 |
|
|
2016
Q4 | – | Sell |
-10,000
| Closed | -$206K | – | 1012 |
|
|
2016
Q3 | $206K | Hold |
10,000
| – | – | ﹤0.01% | 954 |
|
|
2016
Q2 | $306K | Sell |
10,000
-3,000
| -23% | -$91.8K | ﹤0.01% | 884 |
|
|
2016
Q1 | $487K | Hold |
13,000
| – | – | ﹤0.01% | 792 |
|
|
2015
Q4 | $561K | Hold |
13,000
| – | – | ﹤0.01% | 784 |
|
|
2015
Q3 | $487K | Hold |
13,000
| – | – | ﹤0.01% | 791 |
|
|
2015
Q2 | $442K | Hold |
13,000
| – | – | ﹤0.01% | 775 |
|
|
2015
Q1 | $460K | Buy |
+13,000
| New | +$460K | ﹤0.01% | 809 |
|